1Giacomelli S, Gallo D, Apollonio P, et al. Silybin and its bioavailable phospholipid complex (IdB 1016) potentiate in vitro and in vivo the activity of cisplatin[ J]. Life Sci ,2002,70(12): 1447.
2Drew RH, Dodds Ashley E, Benjamin DK Jr, et al. Comparative safety of amphotericin B lipid complex and amphotericin B deoxycholate as aerosolized antifungal prophylaxis in lung-transplant recipients[J]. Transplantation ,2004, 77(2) :232.
3Subira M, Martino R, Sureda A, et al. Safety and efficacy of lowdose amphotericin B lipid complex for empirical antifungal therapy of neutropenic fever in patients with hematologic malignancies[J]. Methods Find Exp Clin Pharmacol,2001,23(9): 505.
4Knoppert DC, Salama HE, Lee DS. Eradication of severe neonatal systemic candidiasis with amphotericin B lipid complex [J]. Ann Pharmacother,2001, 35(9): 1032.
5Herbrecht R, Auvrignon A, Andres E, et al. Efficacy of amphotericin B lipid complex in the treatment of invasive fungal infectuions in immunosuppressed paediatric patients[ J]. Eur J Clin Microbiol Infect Dis ,2001,20(2) :77.
6Laguna F, Videala S, Jimenez-Mejias ME, et al. Amphotericin Blipid complex versus meglumine antimoniate in the treatment of visceral leishmaniasis in patients infected with HIV: a randomized pilot study[ J] .Antimicrob Chemother ,2003, 52(3) :464.
7Gabetta B, Bombardelli E, Pifferi G. Complexes of flavanolignans with phospholipids, preparation thereof and associated pharmaceutical compositions[P] .Eur Patent,209038, 1986-07-07.
